Sub-Analysis Of Large Multi-Center Study Shows DX Technology Provides Similar CRT Responses To Conventional Three-Lead System With Reduced Risk LAKE OSWEGO, Ore., May 27, 2020 /PRNewswire/ — Results recently published in the Journal of Cardiovascular Electrophysiology confirm that BIOTRONIK’s unique two-lead CRT-DX system provides equivalent therapy to more conventional three-lead systems. CRT-DX systems consist of […]
Author: Ken Dropiewski
CARMAT Announces the First Implantation of Its Total Artificial Heart in Denmark
This implant, performed at Rigshospitalet in Copenhagen, marks the resumption of the recruitment in the PIVOTAL study and brings the total number of patients to thirteen CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people […]
Endonovo Therapeutics Enters into $10 million Equity Line Agreement with Cavalry Fund
Agreement Provides Flexible Access to Funding at a Lower Cost of Capital Los Angeles, CA, May 26, 2020 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”) announced today it has executed a new Equity Line Purchase Agreement with Cavalry Fund I, LP (“Cavalry”) to sell up […]
Stereotaxis Announces $15 Million Common Stock Financing
ST. LOUIS, May 26, 2020 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it has entered into a securities purchase agreement with certain funds managed by Consonance Capital Management, a prominent healthcare-focused institutional investor. Stereotaxis is […]
Merit Medical Receives CE Mark for Wrapsody™ Endovascular Stent Graft System
SOUTH JORDAN, Utah, May 26, 2020 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, today announced that it received the CE mark for the WRAPSODY™ […]
TransMedics Announces Proposed Public Offering of Common Stock
ANDOVER, Mass., May 26, 2020 (GLOBE NEWSWIRE) — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, announced today the commencement of a proposed public offering of $60 million of its shares of common […]
Biofourmis names new CFO to help drive the digital therapeutics start-up’s growth plans
Finance leader Matt Borowiecki brings deep M&A and fundraising experience to his new role BOSTON, May 26, 2020 /PRNewswire/ — Biofourmis, a fast-growing global leader in digital therapeutics that powers personally predictive care, has named Matt Borowiecki its Chief Financial Officer (CFO) to enhance decision-making related to future strategic investments, and to expand the company’s […]
Bardy Diagnostics® Announces CE Mark Certification for 14-Day Carnation® Ambulatory Monitor (CAM®) Patch in Europe and Expansion of Home Enrollment Program Amidst COVID-19 Crisis
SEATTLE, May 26, 2020 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today it received CE mark certification for the 14-Day version of the Carnation Ambulatory Monitor (“CAM”) patch, the industry’s only P-wave centric ambulatory cardiac patch monitor and arrhythmia detection device. […]
Ra Medical Systems Receives Continued Listing Standard Notice from the NYSE
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (“Ra Medical”) (NYSE: RMED), a commercial-stage medical device company leveraging its advanced excimer laser-based platform for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases, today announced receipt of written notice from The New York Stock Exchange (the “NYSE”) indicating that Ra […]
Correvio Obtains Final Order for Plan of Arrangement
VANCOUVER, May 21, 2020 /PRNewswire/ – Correvio Pharma Corp. (“Correvio” or the “Company“) (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has obtained a final order from the Supreme Court of British Columbia approving the previously announced plan of arrangement (the “Arrangement“) with ADVANZ PHARMA Corp. Limited […]



